Idogen

Idogen about the conference in Boston and the plans ahead

Christina Herder, acting CEO of the biotechnology company Idogen, joined BioStock's studio to talk about the company's participation at the 6th...

March 8, 2023
Idogen

Idogen one of ten companies selected for world-leading meeting

The biotechnology company Idogen was invited to participate in The Guthy Jackson Charitable Foundation's "20rd Summit for NMOSD Tolerization" on January 22-3...

February 7
Sarah Lidé

VILDA – new network for female leaders in life science

In December 2022, Anna Törner, Cecilia Bröms-Thell and Sarah Lidé announced that they were starting a new network for women...

January 16
Idogen

Idogen strengthens fund for clinical study in 2023

The subscription period has now begun in Idogen's rights issue, which will enable continued development within the spearhead program IDO 8 in patients with...

December 22
The value of patent protection in life science

The value of patent protection in life science

Inventing, developing and launching new pharmaceuticals and medical devices is a long, capital-intensive and risky process. Ownership and...

December 14
watch all presentations and interviews

BioStock Life Science Fall Summit - see all features!

For the fifth year, we invited you to the BioStock Life Science Summit and now you can see all the features here!...

December 8
Jan Holgersson

Idogen strengthens the board with Jan Holgersson

Idogen strengthens the board with Professor Jan Holgersson, who has extensive experience in immunology and has also been involved...

November 25
Idogen

Idogen's acting CEO comments on the share issue

The biotechnology company Idogen is in the clinical phase with the cell therapy program IDO 8, which aims to restore the effect of factor VIII...

November 18
Hanjing Xie

First hemophilia patient enters Idogen's study

The first patient with hemophilia A has now been included in Idogen's clinical phase I/IIa study with the company's cell therapy within IDO...

20 October 2022
Joakim Soderstrom

Exciting times for Idogen's new chairman of the board

On September 6, an extraordinary general meeting was held in Idogen where Joakim Söderström and Niklas Wallett were elected as chairmen of the board...

September 27
Idogen's acting CEO at BIM 2022

BioStock Investor Meeting: Interview with Idogen

In connection with the BioStock Investor Meeting in Stockholm, BioStock took the opportunity to interview Christina Herder, Idogen's newly appointed interim CEO....

September 26
Erika Samuelsson new CDO at Cyxone

Erika Samuelsson new CDO at Cyxone

At the beginning of the autumn, First North company Cyxone announced that it had recruited Erika Samuelsson as new Chief Development Officer with...

September 22